| Market Cap | ₹22,676Cr |
| ROE | 18.36% |
| P/E Ratio(TTM) | 27.02 |
| EPS(TTM) | 183.46 |
| P/B Ratio | 5.89 |
| Dividend Yield | 3.33% |
| Industry P/E | 39.95 |
| Book Value | 841.20 |
| Debt to Equity | 0.01 |
| Face Value | 10 |
| Parent Organisation | Pfizer Limited |
| Managing Director | Meenakshi Nevatia |
| Founded | 1950 |
| NSE Symbol | PFIZER |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 40.72 | ||
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 43.92 | ||
| Astrazeneca Pharma India | NA (0.00%) | 113.38 | ||
| Sanofi Consumer Healthcare India | NA (0.00%) | 48.48 |